Table 2 Simple linear regression analyses of factors associated with BDI-21
From: Depression and anxiety in epilepsy: the association with demographic and seizure-related variables
95% Confidence interval | ||||||
|---|---|---|---|---|---|---|
Factor | Unstandardized coefficient | Lower bound | Upper bound | Standardized coefficients | p Value | R2 |
Gender | 1.991 | -0.036 | 4.018 | 0.136 | 0.054 | 0.018 |
Seizure frequency > 1/month | 4.888 | 2.588 | 7.187 | 0.285 | < 0.001 | 0.081 |
Seizure frequency < 1/year | -2.129 | -4.305 | 0.046 | -0.136 | 0.055 | 0.018 |
Seizure frequency > 1/year | -1.728 | -3.773 | 0.317 | -0.117 | 0.097 | 0.014 |
Symptomatic focal epilepsy | 3.605 | 1.621 | 5.588 | 0.246 | < 0.001 | 0.061 |
Cryptogenic Focal Epilepsy | -1.691 | -3.973 | 0.591 | -0.103 | 0.145 | 0.103 |
Idiopathic generalized epilepsy | -3.357 | -5.806 | -0.907 | -0.188 | 0.007 | 0.035 |
Antiepileptic drug 1 | -2.523 | -4.538 | -0.508 | -0.172 | 0.014 | 0.030 |
Antiepileptic drug 1 | 1.064 | -1.077 | 3.206 | 0.069 | 0.328 | 0.005 |
Antiepileptic drug 1 | 3.065 | 0.227 | 5.904 | 0.149 | 0.034 | 0.022 |
Age | -0.040 | -0.142 | 0.062 | -0.054 | 0.443 | 0.003 |
Duration of disease | -0.036 | -0.145 | 0.073 | -0.046 | 0.516 | 0.002 |